✦ LIBER ✦

Cryptococcal cerebellitis after chemotherapy and autologous stem cell re-infusion in a patient with multiple myeloma

✍ Scribed by W. Fickweiler; M. J. H. Aries; R. H. Enting; E. Vellenga; J. De Keyser

Publisher: Springer
Year: 2009
Tongue: English
Weight: 176 KB
Volume: 256
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-009-0127-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful autologous stem cell transpla

Successful autologous stem cell transplantation in Gaucher disease patient with multiple myeloma

✍ Alexandre Aubourg; Lotfi Benboubker; Laurence Picon; Philippe Goupille; Francois 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Myeloma cell contamination of peripheral

Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

✍ Wichard Vogel; Hans-Georg Kopp; Lothar Kanz; Hermann Einsele 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 245 KB

IgD multiple myeloma—a clinical profile

IgD multiple myeloma—a clinical profile and outcome with chemotherapy and autologous stem cell transplantation

✍ Ashutosh Wechalekar; Dominic Amato; Chris Chen; A. Keith Stewart; Donna Reece 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 70 KB

Serum concentrations of Dickkopf-1 prote

Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation

✍ Marianna C. Politou; Deborah J. Heath; Amin Rahemtulla; Richard Szydlo; Athanasi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 1 views

## Abstract Dickkopf‐1 (DKK‐1) protein, a soluble inhibitor of Wnt signalling, has been implicated in the pathogenesis of myeloma bone disease through the suppression of osteoblast differentiation. In this study, serum concentrations of DKK‐1 were measured in 50 myeloma patients (32 at diagnosis an

Infectious complications after autologou

Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma

✍ H. Auner; H. Sill; A. Mulabecirovic; W. Linkesch; R. Krause 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 30 KB

Comparison of fixed dose pegfilgrastim a

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

✍ Felicetto Ferrara; Tiziana Izzo; Clelia Criscuolo; Cira Riccardi; Assunta Viola; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract Different authors have explored the feasibility of autografting patients with multiple myeloma (MM) on an outpatient basis. Peg‐filgrastim (PEG), a long‐acting recombinant G‐CSF, has similar efficacy when compared to conventional G‐CSF for chemotherapy‐induced neutropenia, but little is